Jul 05 2009
The National Pharmacy Association (NPA) and Allergy UK are offering the community pharmacy allergy screening service to members of the public attending the Hampton Court Palace Flower Show from 7 July to 12 July.
Representatives from the NPA and Allergy UK will be at Hampton Court Palace Flower Show answering people’s questions on allergy and arranging appointments for allergy Continue Reading »
Comments Off
Jul 03 2009
Like astronomers counting stars in the familiar universe of outer space, chemists in Switzerland are reporting the latest results of a survey of chemical space - the so-called chemical universe where tomorrow’s miracle drugs may reside. The scientists conclude, based on this phase of the ongoing count, that there are 970 million chemicals suitable for study as new drugs. Scheduled for the July 1 issue of the Journal of the American Chemical Society, Continue Reading »
Comments Off
Jul 01 2009
Daily sex (or ejaculating daily) for seven days improves men’s sperm quality by reducing the amount of DNA damage, according to an Australian study presented today (Tuesday) to the 25th annual meeting of the European Society of Human Reproduction and Embryology in Amsterdam.
Until now there has been no evidence-based consensus amongst fertility specialists as to whether or not men should refrain from sex for a few days before attempting to conceive Continue Reading »
Comments Off
Jun 29 2009
Identifying and treating depression, including increasing physical activity, may improve quality of life and reduce cardiovascular disease and death in African Americans, according to reports presented at the American Heart Association’s 2009 Conference on Nutrition, Physical Activity and Metabolism.
In one study, researchers in the Jackson Heart Study (JHS) found high depressive symptoms were prevalent Continue Reading »
Comments Off
Jun 27 2009
Cytos Biotechnology Ltd (SIX:CYTN) announced results from a biochemical analysis from a phase IIa study (study 02) with the vaccine
candidate CYT006-AngQb for the treatment of hypertension. CYT006-AngQb has demonstrated in a
first phase IIa study (study 01) a significant reduction of the day-time ambulatory blood pressure of
-9 / -4 mmHg (systolic/diastolic) vs. placebo ( Continue Reading »
Comments Off